DuckWiseArchive › MRK
MRK trade ideas: every closed DuckWise idea on Merck & Company, Inc.
DuckWise has published 3 ideas on Merck & Company, Inc. (MRK, Stock) that have closed between May 2020 and October 2021. Each is listed below with the levels published before the position was taken and its result at close — 3 in profit, 0 at a loss.
| Opened | Closed | Side | Entry | Stop | Projection | Close | Result | Days |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2021 | Oct 4, 2021 | Long | 75.86 | — | 88 | 83.57 | +10.16% | 242 |
| Jun 15, 2020 | Jul 17, 2020 | Long | 74.40 | — | 87.25 | 83.58 | +12.34% | 32 |
| May 22, 2020 | Jun 3, 2020 | Long | 76.38 | — | 83 | 82.67 | +8.24% | 12 |
Prices in US dollars. Result is the price change from the published entry to the published close, before fees, taxes and slippage. How results are counted.
About Merck & Company, Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. Pays a dividend yield of 2.36% annually.
These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell MRK or any other security.